Last updated on March 2019

Post Authorisation Safety Study With Raxone in LHON Patients


Brief description of study

This study is a multicentre, prospective, non-interventional post-authorisation safety study (PASS) of the clinical outcomes for patients with LHON treated with Raxone.

No medication will be provided as part of this study. Raxone will be obtained through commercial channels.

Clinical Study Identifier: NCT02771379

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.